Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1
Dados Bibliográficos
| ID | 14745802 |
|---|---|
| Autores | Min Fu (0000-0001-9117-1232, Hubei University of Chinese Medicine), Yanju Liu (0000-0003-2231-1232, Hubei University of Chinese Medicine), Huanbo Cheng (Hubei University of Chinese Medicine), Kang Xu (0000-0002-6946-8635, Hubei University of Chinese Medicine, autor correspondente), Guangzhong Wang, Guang‐Zhong Wang (0000-0001-6432-8310, Hubei University of Chinese Medicine, autor correspondente) |
| Ano | 2022 |
| Volume | 284 |
| Páginas | 114771 |
| Data de publicação | 2022-02-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Journal of Ethnopharmacology (JOURNAL) |
| Identificadores do periódico | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2021.114771 |
| PMID | 34737010 |
| OpenAlex | W3210982474 |
| Idioma | EN |
| Citações recebidas | 2 |
| Referências citadas | 35 |
Apoptosis · Biology · Coptis · Coptis chinensis · Decoction · MTT assay · Pathology · Stomach · Traditional Chinese medicine · Traditional medicine · Viability assay · Berberine and alkaloids research · Cancer Mechanisms and Therapy · Cancer, Lipids, and Metabolism · Medicine · Biochemistry · Internal Medicine · Pharmacology
Global cancer statistics 2018
Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation
Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways
Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment
Pharmacological effect of prohibited combination pair Panax ginseng and Veratrum nigrum on colorectal metastasis in vitro and in vivo
| Obras citantes distintas | 2 |
|---|---|
| Citações por ano | 0,5 |
| Intervalo de citações | 2022 - 2025 (4) |
| Velocidade de citação | recent |
| Altamente citado | Não |
| Tipos de citação | Neutras: 2 |